Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Immunology. Close to the edge: neutralizing the HIV-1 envelope.

Nabel GJ.

Science. 2005 Jun 24;308(5730):1878-9. No abstract available.

PMID:
15976295
2.

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

Haynes BF, Fleming J, St Clair EW, Katinger H, Stiegler G, Kunert R, Robinson J, Scearce RM, Plonk K, Staats HF, Ortel TL, Liao HX, Alam SM.

Science. 2005 Jun 24;308(5730):1906-8.

3.

HIV vaccine design and the neutralizing antibody problem.

Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT.

Nat Immunol. 2004 Mar;5(3):233-6. No abstract available.

PMID:
14985706
4.

Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.

Maeso R, Huarte N, Julien JP, Kunert R, Pai EF, Nieva JL.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):863-76. doi: 10.1089/AID.2010.0265.

PMID:
21142698
5.

Fusion-competent vaccines: broad neutralization of primary isolates of HIV.

LaCasse RA, Follis KE, Trahey M, Scarborough JD, Littman DR, Nunberg JH.

Science. 1999 Jan 15;283(5400):357-62. Retraction in: Nunberg JH. Science. 2002 May 10;296(5570):1025.

6.

Neutralizing antibodies against HIV -- back in the major leagues?

Ferrantelli F, Ruprecht RM.

Curr Opin Immunol. 2002 Aug;14(4):495-502. Review.

PMID:
12088685
7.

Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.

Ye L, Wen Z, Dong K, Wang X, Bu Z, Zhang H, Compans RW, Yang C.

PLoS One. 2011;6(5):e14813. doi: 10.1371/journal.pone.0014813.

8.

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.

Parren PW, Gauduin MC, Koup RA, Poignard P, Fisicaro P, Burton DR, Sattentau QJ.

Immunol Lett. 1997 Jun 1;57(1-3):105-12. Review. Corrected and republished in: Immunol Lett. 1997 Jul;58(2):125-32.

PMID:
9232434
9.

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".

Parren PW, Gauduin MC, Koup RA, Poignard P, Sattentau QJ, Fisicaro P, Burton DR.

Immunol Lett. 1997 Jul;58(2):125-32. Review.

PMID:
9271324
10.

Early fall of antibodies against the motif 583-599 of gp41 in the sera of individuals with HIV-1 infection.

Echaniz P, Sola MD, Cuadrado E.

Vox Sang. 1994;66(1):86-7. No abstract available.

PMID:
7511854
11.

Neutralizing antibodies take a swipe at HIV in vivo.

Montefiori DC.

Nat Med. 2005 Jun;11(6):593-4. No abstract available.

PMID:
15937465
12.

Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity.

Scherer EM, Zwick MB, Teyton L, Burton DR.

AIDS. 2007 Oct 18;21(16):2131-9.

PMID:
18090039
13.

The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.

Wyatt R, Sodroski J.

Science. 1998 Jun 19;280(5371):1884-8. Review.

PMID:
9632381
15.

The role of neutralizing antibodies in HIV infection.

Humbert M, Dietrich U.

AIDS Rev. 2006 Apr-Jun;8(2):51-9. Review.

PMID:
16848273
16.

Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.

Ye L, Sun Y, Lin J, Bu Z, Wu Q, Jiang S, Steinhauer DA, Compans RW, Yang C.

Virology. 2006 Aug 15;352(1):74-85.

17.

Passive immunization for the prevention and treatment of HIV infection.

Zolla-Pazner S, Gorny MK.

AIDS. 1992 Nov;6(11):1235-47. No abstract available.

PMID:
1472330
18.

Broadly neutralizing antibodies against HIV-1: templates for a vaccine.

van Gils MJ, Sanders RW.

Virology. 2013 Jan 5;435(1):46-56. doi: 10.1016/j.virol.2012.10.004. Review.

19.

Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.

Bryson S, Julien JP, Isenman DE, Kunert R, Katinger H, Pai EF.

J Mol Biol. 2008 Oct 17;382(4):910-9. doi: 10.1016/j.jmb.2008.07.057.

PMID:
18692506
20.

Neutralizing antibodies to HIV-1 induced by immunization.

McCoy LE, Weiss RA.

J Exp Med. 2013 Feb 11;210(2):209-23. doi: 10.1084/jem.20121827. Review.

Items per page

Supplemental Content

Support Center